HeLa Cell Transformants Overproducing Mouse Metallothionein Showin vivoResistance tocis-Platinum in Nude Mice
- 1 January 2000
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 91 (1) , 91-98
- https://doi.org/10.1111/j.1349-7006.2000.tb00864.x
Abstract
Plasmid pSV2MT‐I encoding mouse metallothionein‐I (MT‐I) designed to be expressed under the control of an SV40 promoter was introduced into human HeLa S3 cells. Several transformants (HeLa/MTH) carrying multi‐copies of mouse MT‐I cDNA in their genomes were isolated. These transformants produced 4 to 20‐fold larger amounts of MT than their parent cells. The MT levels in HeLa/MTH were well correlated with the extent of resistance to cadmium, but not with that to cis‐platinum (cis‐DDP) in vitro. To study the role of MT in resistance to cis‐DDP in vivo, nude mice were inoculated subcutaneously with two independent HeLa/MTH clones. MT levels in these tumors were about 3‐fold higher than those in the parental cells. The growth of tumors derived from either HeLa/MTH clone was not inhibited in the presence of 15 μmol/kg of cis‐DDP, which completely inhibited the growth of tumors derived from the parental HeLa cells. These data strongly suggest that the elevated level of MT confers resistance to cis‐DDP in vivo but not in vitro. Thus, the results of this study indicate that in vitro determinations of the influence of MT on cis‐DDP resistance may underestimate its importance in in vivo situations.Keywords
This publication has 43 references indexed in Scilit:
- Tumours from a Cell Strain with a High Content of Metallothionein Show Enhanced Resistance against Cis-DichlorodiammineplatinumActa Pharmacologica et Toxicologica, 2009
- In vivo cisplatin resistance of rat ascites hepatoma AH66Cancer Letters, 1996
- Differential effects on cell killing in metallothionein overexpressing CHO mutant cell linesCarcinogenesis: Integrative Cancer Research, 1990
- A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugsToxicology Letters, 1990
- Prevention of adverse effects of γ-ray irradiation after metallothionein induction by bismuth subnitrate in miceEuropean Journal of Cancer and Clinical Oncology, 1989
- Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heartToxicology, 1988
- Specific Reduction of Toxic Side Effects of Adriamycin by Induction of Metallothionein in MiceJapanese Journal of Cancer Research, 1988
- Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicalsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothioneinToxicology and Applied Pharmacology, 1981
- Binding of glutathione-depleting agents to metallothioneinToxicology and Applied Pharmacology, 1980